Insider Trading Activity AngioDynamics, Inc. (NASDAQ:ANGO) – CEO Bought 20,000 shares of Stock

Insider Trading Activity For AngioDynamics, Inc. (NASDAQ:ANGO)

Story continues below

James C Clemmer , CEO of AngioDynamics, Inc. (NASDAQ:ANGO) reportedly Bought 20,000 shares of the company’s stock at an average price of 15.64 for a total transaction amount of $312,800.00 SEC Form

Insider Trading History For AngioDynamics, Inc. (NASDAQ:ANGO)

  • On 11/5/2012 Jeffrey Gold, Director, bought 1,000 with an average share price of $10.56 per share and the total transaction amounting to $10,560.00.View SEC Filing
  • On 1/11/2013 Kevin J Gould, Director, bought 2,700 with an average share price of $11.58 per share and the total transaction amounting to $31,266.00.View SEC Filing
  • On 2/14/2013 Vincent Bucci, Director, bought 2,000 with an average share price of $12.17 per share and the total transaction amounting to $24,340.00.View SEC Filing
  • On 3/12/2013 Vincent Bucci, Director, bought 85,000 with an average share price of $10.77 per share and the total transaction amounting to $915,450.00.View SEC Filing
  • On 5/9/2013 Charles R Greiner, VP, sold 1,495 with an average share price of $10.38 per share and the total transaction amounting to $15,518.10.View SEC Filing
  • On 7/22/2013 Kevin J Gould, Director, bought 2,700 with an average share price of $12.00 per share and the total transaction amounting to $32,400.00.View SEC Filing
  • On 10/17/2013 Howard W Donnelly, Director, sold 20,000 with an average share price of $15.06 per share and the total transaction amounting to $301,200.00.View SEC Filing
  • Analyst Ratings For AngioDynamics, Inc. (NASDAQ:ANGO)
    These are 2 Hold Ratings, 3 Buy Ratings .
    The current consensus rating for AngioDynamics, Inc. (NASDAQ:ANGO) is Buy (Score: 2.60) with a consensus target price of $18.40 , a potential (17.57% upside)

    Analyst Ratings History For AngioDynamics, Inc. (NASDAQ:ANGO)

    • On 9/23/2015 Sidoti Initiated Coverage of rating Neutral with a price target of $14.50
    • On 11/10/2015 Raymond James Financial, Inc. Downgraded rating Outperform to Market Perform
    • On 4/8/2016 Piper Jaffray Companies Initiated Coverage of rating Neutral with a price target of $12.00
    • On 9/12/2016 KeyCorp Set Price Target of rating Buy with a price target of $18.00
    • On 4/1/2017 Craig Hallum Set Price Target of rating Buy with a price target of $20.00
    • On 7/4/2017 Cantor Fitzgerald Boost Price Target of rating Overweight with a price target of $20.00 to $21.00
    • On 7/18/2017 Canaccord Genuity Reiterated Rating Hold with a price target of $17.00

    Recent Trading Activity for AngioDynamics, Inc. (NASDAQ:ANGO)
    Shares of AngioDynamics, Inc. closed the previous trading session at 15.65 down -0.10 -0.63% with 324,690 shares trading hands.

    An ad to help with our costs